{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:26:12Z","timestamp":1761164772325,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ejpn.2022.08.008","type":"journal-article","created":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T20:42:50Z","timestamp":1661632970000},"page":"A4-A5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Provoked seizures might lead to a significant diagnosis delay in CLN2"],"prefix":"10.1016","volume":"40","author":[{"given":"Zvonka","family":"Rener-Primec","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2022.08.008_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpn.2022.06.014","article-title":"Provoked seizures at the onset of progressive disease contribute to diagnosis delay - a tertiary center experience in a cohort of 22 children with CLN2","volume":"40","author":"Kravljanac","year":"2022","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ejpn.2022.08.008_bib2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pediatrneurol.2017.01.034","article-title":"Management strategies for CLN2 disease","volume":"69","author":"Williams","year":"2017","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ejpn.2022.08.008_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejpn.2020.12.002","article-title":"Cerliponase alfa changes the natural history of children with neuronal ceroid lipofuscinosis type 2: The first French cohort","volume":"30","author":"Estublier","year":"2021","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ejpn.2022.08.008_bib4","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S2352-4642(18)30179-2","article-title":"Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study","volume":"2","author":"Nickel","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.ejpn.2022.08.008_bib5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1474-4422(18)30368-5","article-title":"Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis","volume":"18","author":"Mole","year":"2018","journal-title":"Lancet Neurol."}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109037982200126X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109037982200126X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:39:45Z","timestamp":1761071985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109037982200126X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":5,"alternative-id":["S109037982200126X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2022.08.008","relation":{},"ISSN":["1090-3798"],"issn-type":[{"type":"print","value":"1090-3798"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Provoked seizures might lead to a significant diagnosis delay in CLN2","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2022.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd on behalf of European Paediatric Neurology Society.","name":"copyright","label":"Copyright"}]}}